Rocket Report: Europe joins the commercial launch club; a Ravn X sighting?
Welcome to Edition 9.10 of the Rocket Report! This week we’re celebrating a historic moment in Europe when a German rocket company successfully put its
Some in Silicon Valley Are Questioning the Calls for an A.I. Slowdown
The debate over the safety of artificial intelligence grew personal as key tech leaders said calls for government regulation were self-serving and misplaced.
Swedish left-wing bloc narrowly ahead with election too close to call
A partial count by Sweden’s election authority projected that left-wing opposition bloc would win a three-seat majority.
When gut microbes run low on fiber, they may start eating you
Gut microbes need something to eat, and when fiber is limited, they may begin consuming proteins from the mucus lining that protects the gut. Researchers
Trump’s attempt to dodge AI question immediately backfires: ‘As if we don’t know’
President Tweety McTreason stunned reporters Sunday after he was asked about his personal use of artificial intelligence. Trump spoke with the press during his flight
Alarm bells sound as Trump targets $3 billion lifeline that keeps schools online
A multi-billion-dollar federal program that helps schools and libraries afford broadband internet is under review by the Trump administration, leaving education officials and advocates worried
MAKERphone 2.0 Lets You Build a 4G Phone and Vibe-Code Its Apps
Most of us carry a phone every day, but very few of us could say what’s actually going on inside one. That gap is exactly
Privacy Notes: Markdown Editor With Built-in Encrypted Vault
There is no dearth of note taking apps for Linux. There are tools like Obsidian that are local first, tools like Joplin that are both
Low discontinuation rates confirm manageable safety of iza-bren
An investigational EGFR x HER3 antibody-drug conjugate demonstrated promising efficacy with a tolerable safety profile in patients with previously treated EGFR-mutated non-small cell lung cancer
Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination
The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically
Texas Republicans call out railroad commissioner candidate over racist post
Several prominent Texas Republicans on Sunday condemned a racist post by Bo French, a GOP candidate for statewide office to regulate Texas’ oil and gas
Amazon suspends use of 21 Air, cargo carrier involved in fatal Miami crash
Online retailer Amazon said Sunday it was suspending its use of cargo carrier 21 Air after one of its Amazon-branded aircraft crashed upon landing in
From IFA demonstrations to a wider design question: why should an office chair expect the body to stay still?
At IFA Berlin 2026, ARBREST put a chair through movements that office furniture often treats as exceptions. COVE is the new brand’s first product, made